Literature DB >> 11600538

GH is needed for the maturation of muscle mass and strength in adolescents.

L Hulthén1, B A Bengtsson, K S Sunnerhagen, L Hallberg, G Grimby, G Johannsson.   

Abstract

The postpubertal period and the early years of adulthood may be of importance for continuing tissue maturation of importance in adulthood and aging. An example of this is the peak bone mass. This study has evaluated the importance of GH for lean mass and muscle strength in adolescents and young adults. GH treatment was discontinued in 40 adolescents aged 16-21 yr with GH deficiency of childhood onset. Measurements of isometric and isokinetic knee-extensor and flexor strength, handgrip strength, lean body mass, fat-free mass, and total body nitrogen were performed annually for 2 yr. Two hundred fifty healthy adolescents were randomly selected for prospective measurements of lean mass and handgrip strength between the ages of 17 and 21 yr. In the adolescents with continuing GH deficiency, lean body mass decreased, compared with the patients defined as having sufficient endogenous GH. The isometric strength in knee flexors increased in the sufficient endogenous GH group and was unchanged in the GH deficiency group during the 2 yr off GH treatment (between group, P < 0.05). The mean and peak handgrip strength increased on average by 9-15% in the group with sufficient endogenous GH and was unchanged in those with GH deficiency (P < 0.05). Lean body mass and handgrip strength (both, P < 0.001) increased in both the healthy boys and girls who were followed for 4 yr with a more marked increase in the boys. The mean increase in handgrip between the age of 17 and 21 yr was 7-9%. The increased lean mass and improved muscle performance seen in healthy adolescents did not occur in adolescents with GH deficiency. These findings suggest that GH is of importance for the maturation of lean mass and muscle strength in adolescents and young adults.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600538     DOI: 10.1210/jcem.86.10.7897

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Traumatic brain injury in children and adolescents: surveillance for pituitary dysfunction.

Authors:  Kenneth W Norwood; Mark D Deboer; Matthew J Gurka; Michelle N Kuperminc; Alan D Rogol; James A Blackman; Julia B Wamstad; Marcia L Buck; Peter D Patrick
Journal:  Clin Pediatr (Phila)       Date:  2010-08-19       Impact factor: 1.168

Review 2.  Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: the impact on bone mass.

Authors:  G Saggese; G I Baroncelli; T Vanacore; L Fiore; S Ruggieri; G Federico
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 3.  Transitioning of children with GH deficiency to adult dosing: changes in body composition.

Authors:  Vi Thuy Nguyen; Madhusmita Misra
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

4.  Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA.

Authors:  G Aimaretti; R Attanasio; S Cannavò; M C Nicoletti; R Castello; C Di Somma; P Garofalo; L Iughetti; S Loche; M Maghnie; L Mazzanti; G Saggese; M Salerno; G Tonini; V Toscano; S Zucchini; M Cappa
Journal:  J Endocrinol Invest       Date:  2014-11-02       Impact factor: 4.256

Review 5.  The enigmatic role of growth hormone in age-related diseases, cognition, and longevity.

Authors:  Gabriela Colon; Tatiana Saccon; Augusto Schneider; Marcelo B Cavalcante; Derek M Huffman; Darlene Berryman; Ed List; Yuji Ikeno; Nicolas Musi; Andrzej Bartke; John Kopchick; James L Kirkland; Tamara Tchkonia; Michal M Masternak
Journal:  Geroscience       Date:  2019-09-04       Impact factor: 7.713

Review 6.  Growth hormone deficiency in the transition period: body composition and gonad function.

Authors:  G Balercia; L Giovannini; F Paggi; M Spaziani; N Tahani; M Boscaro; A Lenzi; A Radicioni
Journal:  J Endocrinol Invest       Date:  2011-06-21       Impact factor: 4.256

Review 7.  [Congenital adrenal hyperplasia and growth hormone deficiency. Special care in transition to adulthood].

Authors:  H G Dörr; C Schöfl
Journal:  Internist (Berl)       Date:  2009-10       Impact factor: 0.743

Review 8.  Justified and unjustified use of growth hormone.

Authors:  A J van der Lely
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

9.  Provincial disparities of growth hormone coverage for young adult survivors of paediatric brain tumours across Canada.

Authors:  Haroon Hasan; Fuchsia Howard; Steven G Morgan; Daniel L Metzger; Andrea C Lo; Karen Goddard; Sabrina Gill; Michelle Johnson
Journal:  Healthc Policy       Date:  2014-02

10.  Bone mineral density in young adult survivors of acute lymphoblastic leukemia.

Authors:  Inas H Thomas; Janet E Donohue; Kirsten K Ness; Donald R Dengel; K Scott Baker; James G Gurney
Journal:  Cancer       Date:  2008-12-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.